Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata from this November 2019 FDA Warning Letter, Apothecus Pharmaceutical Corp. received a regulatory notice regarding drug manufacturing or compliance issues, though the specific violations cannot be determined without access to the full letter text. The warning falls under FDA's drug product oversight authority, which typically addresses concerns such as manufacturing practices, product quality, labeling, or pre-market approval compliance. Without the complete letter content and specific issuing office designation, the precise nature and scope of the violations remain unclear. Additional documentation would be needed to provide details on the regulatory deficiencies cited.